HealthcareServices

Digital Biology Market Insights Report: Opportunities and Drivers 2030

February 27, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the digital biology market from 2026–2035 with trusted insights from The Business Research Company

By how much is the Digital Biology Market expected to grow between 2026 and 2030?

The digital biology market has seen rapid growth recently. Its value is forecast to climb from $15.97 billion in 2025 to $18 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 12.7%. This historic expansion can be attributed to an increasing supply of high-throughput biological data, the broadening of genomic sequencing activities, an increase in bioinformatics research initiatives, greater adoption of laboratory automation, and enhancements in computational processing power.

The digital biology market size is anticipated to experience substantial growth in the upcoming years, projected to reach $29.37 billion by 2030, expanding at a compound annual growth rate (CAGR) of 13.0%. This growth during the forecast period is attributable to increasing investments in AI-enabled drug discovery, the expansion of personalized medicine research, the growing use of digital biology in agriculture and environment studies, a rising demand for scalable cloud bio platforms, and increasing collaboration between tech and life sciences firms. Key trends expected in the forecast period include the increasing adoption of computational biology platforms, a rising use of AI-driven biological modeling, the growing integration of multi-omics data analysis, the expansion of cloud-based bioinformatics solutions, and an enhanced focus on digital twin biology.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=29018&type=smp

Which Drivers Are Influencing Market Acceleration In The Digital Biology Market?

The rise in healthcare research and development expenditure is projected to advance the growth of the digital biology market moving forward. Healthcare research and development refers to structured efforts aimed at creating, testing, and refining medical treatments, devices, and procedures to improve health outcomes and patient care. This spending is increasing due to the rising demand for innovative treatments and cutting-edge therapies, prompting companies to invest more in developing new drugs, medical devices, and personalized medicine solutions for complex and emerging health challenges. Healthcare research and development funding supports digital biology by financing the creation of advanced computational tools and bioinformatics platforms, which enable faster analysis of biological data and more precise disease modeling, thereby enhancing diagnostics and treatments. For instance, in June 2025, the Department for Science, Innovation and Technology, a UK-based government ministry, announced a $114.38 billion (£86 billion) investment over four years to back science and technology research and development, including drug development, with annual spending of $29.93 billion (£22.5 billion). Thus, the increase in healthcare research and development expenditure is propelling the expansion of the digital biology market.

What Segments Are Identified Within The Structure Of The Digital Biology Market?

The digital biology market covered in this report is segmented –

1) By Component: Software, Hardware, Services

2) By Deployment Mode: On Premises, Cloud

3) By Technology: Artificial Intelligence In Biology, Bioinformatics Tools And Software, Blockchain For Data Integrity, Cloud Computing Solutions, Deoxyribonucleic Acid Data Storage Technology

4) By Application: Drug Discovery, Agriculture, Environmental Monitoring, Personalized Medicine, Synthetic Biology, Bioinformatics, Other Applications

5) By End User: Pharmaceutical and Biotechnology Companies, Research and Academic Institutes, Healthcare Providers, Contract Research Organizations, Government and Regulatory Bodies

Subsegments:

1) By Software: Genomic Data Analysis, Proteomics Analysis, Metabolomics Analysis, Transcriptomics Analysis, Clinical Bioinformatics, Data Visualization Tools, Laboratory Information Management Systems

2) By Hardware: Sequencing Instruments, Mass Spectrometry Systems, Microscopy Instruments, Chromatography Equipment, Cell Culture Instruments, Laboratory Automation Equipment

3) By Services: Bioinformatics Consulting, Data Management Services, Genetic Testing Services, Clinical Trial Support Services, Custom Assay Development, Laboratory Management Services, Training And Support Services

Which Competitive Trends Are Impacting The Structure Of The Digital Biology Market?

Leading companies in the digital biology market are progressively integrating artificial intelligence for purposes of drug discovery and predictive biology. Artificial intelligence streamlines the identification of therapeutic targets, enhances drug development, and supports the formulation of precise, patient-tailored treatments. For example, in December 2024, GenBio AI, a US-based digital biology company, initiated Phase 1 of its AI-Driven Digital Organism (AIDO). This advanced platform facilitates extensive modeling of DNA (deoxyribonucleic acid), RNA (ribonucleic acid), protein, and single-cell expression, furnishing researchers with sophisticated instruments to simulate biological systems and expedite medical research, drug discovery, and the development of personalized therapies.

Which Major Firms Are Strengthening Their Position In The Digital Biology Market?

Major companies operating in the digital biology market are Thermo Fisher Scientific, Illumina Inc., Qiagen N.V., F. Hoffmann-La Roche Ltd., Perkin Elmer, Agilent Technologies Inc., BGI Genomics Co. Ltd., DNAnexus Inc., Seven Bridges Genomics Inc., GenBio Inc., Evogene Ltd., Cradle B.V., Ginkgo Biosecurity, Evolutionary Scale Inc., Naturannova S.A., Nexco Analytics Inc., Latent Labs Inc., BioLizard NV, Lamin Labs Inc., LatchBio Inc., Standard BioTools Inc., Recursion Pharmaceuticals Inc., Insilico Medicine Inc., Deep Genomics Inc., Valo Health Inc., LabGenius Ltd., Arzeda Corp., e-Therapeutics plc, Bio-Map, A-Alpha Bio Inc., Eikon Therapeutics Inc., Proscia Inc., Lifebit Biotech Ltd., Genestack Ltd., Seqera Labs SL, Sciepot, Pluto Biosciences Inc., SciNote LLC, Qlucore AB, 10x Genomics Inc., Bruker Corporation, Bio-Techne Corporation, Resolve Biosciences GmbH, RareCyte Inc., Oxford Nanopore Technologies plc, PacBio, Ultima Genomics Inc., Element Biosciences Inc., Benchling Inc., and Synthace Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/digital-biology-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Digital Biology Market?

North America was the largest region in the digital biology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital biology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Digital Biology Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=29018&type=smp

Browse Through More Reports Similar to the Global Digital Biology Market 2026, By The Business Research Company

Digital Genome Market Report 2026

https://www.thebusinessresearchcompany.com/report/digital-genome-global-market-report

Computational Biology Market Report 2026

https://www.thebusinessresearchcompany.com/report/computational-biology-global-market-report

Digital Health Market Report 2026

https://www.thebusinessresearchcompany.com/report/digital-health-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795